TEKT2 and metastatic malignant neoplasm in the lymph nodes: In summary, we constructed a lymph node metastasis-related predictive signature based on TEKT2 and RPGR expression to predict the prognosis, immune infiltration, and efficiency of individualized therapeutic agents.